IDH1 and cancer: H3/IDH1 wildtype pHGGs have previously been shown to be a diverse group of tumors with mutations in many cancer pathways [35, 37, 51], but have not been directly linked to any particular epigenetic driver as is the case with H3 and IDH1 mutant tumors.